ESSENTIAL in Small Vessels Registry

International, multicenter, prospective and observational registry. Percutaneous coronary intervention for treating de-novo lesions in small coronary vessels with essential. Published in Coronary Artery Disease, 29(6):477-481, September 2018.

DESCRIPTION

Device

Essential

Number of patients

71

Follow up

12-month

Type of lesions

de – novo lesions in small coronary vessels

OUTCOMES

Primary endpoint

Target lesion failure (TLF)

Secondary endpoint

Global MACE

Rodés-Cabau J. Coronary Artery Disease. 29(6):477 481, September 2018

CONCLUSIONS

“These results show this treatment strategy may be a reliable alternative for small coronary vessels”

These data suggest the use of the Essential for treating de-novo coronary lesions in small coronary vessels was safe and associated with low rates of clinical events at the 12-month follow-up.

Published in Coronary Artery Disease, 29(6):477-481, September 2018.

MAIN INVESTIGATOR

Dr Josep Rodés-Cabau (PI)
Quebec Heart and Lung Institute (Quebec, CAN)

ALL CLINICAL TRIALS

Get in touch with us

Contact